02/19/2015 - 11:44am

CRN files second amicus brief challenging FTC "rigid standard" in evaluating supplement claims.

02/19/2015 - 11:44am

Proposed New York legislation could mean big changes for some beauty brands.

02/17/2015 - 9:12am

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

02/13/2015 - 11:38am

In response to the New York Attorney General’s recent recall of herbal supplements from four major retailers, the Council for Responsible Nutrition has assembled a microsite for consumers.

02/12/2015 - 4:00pm

The House Energy and Commerce Committee passed legislation to help curb prescription drug diversion and abuse and protect patients in need of medication.

02/12/2015 - 1:52pm

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Thursday introduced companion legislation to House bill H.R. 471.

 

02/10/2015 - 9:06am

GNC on Monday announced that it refuted the claims made by the New York State Attorney General in his Feb. 2 letter.

02/09/2015 - 1:26pm

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

02/09/2015 - 11:34am

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar.